2011•Chinese Heart JournalRequires access

Prevalence and risk factors of clopidogrel resistance after percutaneous coronary intervention in patients over 60 years of age

Zhizhong Li

Open publisher page 0 citations

Abstract

AIM: To assess the incidence and risk factors of clopidogrel resistance after percutaneous coronary intervention(PCI) with drug-eluting stent in patients 60 years of age.METHODS: The clinical data of 208 patients were collected,among whom 55 patients whose PAR 50% after PCI were assigned to the clopidogrel resistance group and the other 153 patients were assigned to the without resistance group.Correlation factors were analyzed and compared between groups.RESULTS: The incidence of clopidogrel resistance was 26.4% in elderly patients.The level of PAR was(57±6)% vs.(35±9)%(P0.01) between the two groups after PCI.Multivariate logistic regression models found that the risk factor was diabetes mellitus(P=0.037,OR 2.053,95% CI 1.045-4.034).CONCLUSION: The incidence of clopidogrel resistance is 26.4% after PCI with drug-eluting stent in patients 60 years of age,and diabetes mellitus is the risk factor for clopidogrel resistance.

About this research paper

What this paper is about

AIM: To assess the incidence and risk factors of clopidogrel resistance after percutaneous coronary intervention(PCI) with drug-eluting stent in patients 60 years of age.METHODS: The clinical data of 208 patients were collected,among whom 55 patients whose PAR 50% after PCI were assigned to the clopidogrel resistance group and the other 153 patients were assigned to the without resistance group.Correlation factors were analyzed and compared between groups.RESULTS: The incidence of clopidogrel resistance was 26.4% in elderly patients.The level of PAR was(57±6)% vs.(35±9)%(P0.01) between the two groups after PCI.Multivariate logistic regression models found that the risk factor was diabetes mellitus(P=0.037,OR 2.053,95% CI 1.045-4.034).CONCLUSION: The incidence of clopidogrel resistance is 26.4% after PCI with drug-eluting stent in patients 60 years of age,and diabetes mellitus is the risk factor for clopidogrel resistance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To assess the incidence and risk factors of clopidogrel resistance after percutaneous coronary intervention(PCI) with drug-eluting stent in patients 60 years of age.METHODS: The clinical data of 208 patients were collected,among whom 55 patients whose PAR 50% after PCI were assigned to the clopidogrel resistance group and the other 153 patients were assigned to the without resistance group.Correlation factors were analyzed and compared between groups.RESULTS: The incidence of clopidogrel resistance was 26.4% in elderly patients.The level of PAR was(57±6)% vs.(35±9)%(P0.01) between the two groups after PCI.Multivariate logistic regression models found that the risk factor was diabetes mellitus(P=0.037,OR 2.053,95% CI 1.045-4.034).CONCLUSION: The incidence of clopidogrel resistance is 26.4% after PCI with drug-eluting stent in patients 60 years of age,and diabetes mellitus is the risk factor for clopidogrel resistance.

Key concepts: Medicine, Clopidogrel, Percutaneous coronary intervention, Conventional PCI, Internal medicine, Incidence (geometry), Diabetes mellitus, Risk factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Prevalence and risk factors of clopidogrel resistance after percutaneous coronary intervention in patients over 60 years of age — Research Paper | ScholarLens